{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:26:59Z","timestamp":1778524019101,"version":"3.51.4"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.regpep.2013.08.005","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T01:01:36Z","timestamp":1377651696000},"page":"123-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line"],"prefix":"10.1016","volume":"186","author":[{"given":"Lorna A.","family":"Farrelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niall T.P.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"O'Callaghan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Toulouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz M.","family":"Yilmazer-Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2013.08.005_bb0005","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y\u2014a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.regpep.2013.08.005_bb0010","doi-asserted-by":"crossref","first-page":"11974","DOI":"10.1016\/S0021-9258(18)67189-3","article-title":"Characterization, sequence, and expression of the cloned human neuropeptide Y gene","volume":"261","author":"Minth","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.regpep.2013.08.005_bb0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0163-7258(95)98598-K","article-title":"Central nervous system pharmacology of neuropeptide Y","volume":"65","author":"Wettstein","year":"1995","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.regpep.2013.08.005_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.npep.2004.05.002","article-title":"The NPY, system in stress, anxiety and depression","volume":"38","author":"Heilig","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.regpep.2013.08.005_bb0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/FBP.0b013e32830dc0de","article-title":"Morphological correlates of emotional and cognitive behaviour: insights from studies on inbred and outbred rodent strains and their crosses","volume":"19","author":"Yilmazer-Hanke","year":"2008","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1535-7597.2003.03208.x","article-title":"Neuropeptide Y and epilepsy","volume":"3","author":"Colmers","year":"2003","journal-title":"Epilepsy Curr Am Epilepsy Soc"},{"key":"10.1016\/j.regpep.2013.08.005_bb0035","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbd.2006.12.014","article-title":"Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus","volume":"26","author":"Howell","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.regpep.2013.08.005_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-8981(02)00301-7","article-title":"Neuropeptide Y and its receptors as potential therapeutic drug targets","volume":"326","author":"Silva","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.regpep.2013.08.005_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.npep.2004.07.001","article-title":"Neuropeptide Y and seizures: effects of exogenously applied ligands","volume":"38","author":"Woldbye","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.regpep.2013.08.005_bb0050","first-page":"371","article-title":"Neuropeptide Y family of peptides: structure, anatomical expression, function, and molecular evolution","volume":"78","author":"Cerda-Reverter","year":"2000","journal-title":"Biochim Biol Cell"},{"key":"10.1016\/j.regpep.2013.08.005_bb0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1600-0447.1990.tb01366.x","article-title":"Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses","volume":"82","author":"Heilig","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.regpep.2013.08.005_bb0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0278-5846(89)90003-1","article-title":"Neuropeptide Y (NPY) and the central nervous system: distribution effects and possible relationship to neurological and psychiatric disorders","volume":"13","author":"Wahlestedt","year":"1989","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.regpep.2013.08.005_bb0065","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1749-6632.1990.tb48931.x","article-title":"Neuropeptide Y in cortex and striatum. Ultrastructural distribution and coexistence with classical neurotransmitters and neuropeptides","volume":"611","author":"Aoki","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0070","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnana.2010.00150","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons","volume":"4","author":"Tepper","year":"2010","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.regpep.2013.08.005_bb0075","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(96)00801-3","article-title":"Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats","volume":"735","author":"Figueredo-Cardenas","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0080","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1679\/aohc.58.523","article-title":"Colocalization of neuropeptide Y with other neurochemical markers in the guinea-pig small intestine","volume":"58","author":"Uemura","year":"1995","journal-title":"Arch Histol Cytol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0085","doi-asserted-by":"crossref","first-page":"11100","DOI":"10.1073\/pnas.0501988102","article-title":"Expression, physiological action, and coexpression patterns of neuropeptide Y in rat taste-bud cells","volume":"102","author":"Zhao","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2013.08.005_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004410050814","article-title":"Coexpression of neuropeptide Y and vasoactive intestinal polypeptide in pelvic plexus neurones innervating the uterus and cervix in the rat","volume":"288","author":"Houdeau","year":"1997","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0095","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0022-5347(17)32570-3","article-title":"Colocalization of nitric oxide synthase with vasoactive intestinal peptide, neuropeptide Y, and tyrosine hydroxylase in nerves supplying the human ureter","volume":"152","author":"Smet","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00302967","article-title":"Vasoactive intestinal polypeptide and acetylcholine coexist with neuropeptide Y, dopamine-beta-hydroxylase, tyrosine hydroxylase, substance P or calcitonin gene-related peptide in neuronal subpopulations in cranial parasympathetic ganglia of rat","volume":"267","author":"Hardebo","year":"1992","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0022-2828(92)91157-Z","article-title":"Distribution of the neuropeptide galanin in the cat heart and coexistence with vasoactive intestinal peptide, substance P and neuropeptide Y","volume":"24","author":"Zhu","year":"1992","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0304-3940(90)90756-Y","article-title":"Distribution of Met-enkephalyl-Arg-Gly-Leu in rat larynx: partial coexistence with vasoactive intestinal polypeptide, peptide histidine isoleucine and neuropeptide Y","volume":"119","author":"Krekel","year":"1990","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.regpep.2013.08.005_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2011.03.011","article-title":"The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer","volume":"131","author":"Zhang","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.regpep.2013.08.005_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.npep.2004.04.006","article-title":"Neuropeptide Y, and epilepsy: recent progress, prospects and controversies","volume":"38","author":"Baraban","year":"2004","journal-title":"Neuropeptides"},{"key":"10.1016\/j.regpep.2013.08.005_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2011.05.033","article-title":"Influence of neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study","volume":"1407","author":"Crespi","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0130","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1016\/S0024-3205(02)02159-8","article-title":"Neuropeptide Y (NPY) and depression: from animal studies to the human condition","volume":"71","author":"Redrobe","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0135","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.brainres.2009.09.077","article-title":"A possible role of neuropeptide Y in depression and stress","volume":"1314","author":"Morales-Medina","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0140","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.regpep.2013.08.005_bb0145","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.biopsych.2009.11.008","article-title":"Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment","volume":"67","author":"Sgobio","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.regpep.2013.08.005_bb0150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjp.0707253","article-title":"Tricyclic antidepressant pharmacology and therapeutic drug interactions updated","volume":"151","author":"Gillman","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3724\/SP.J.1041.2009.00053","article-title":"Effects of antidepressants on the expression of neuropeptide Y in brain of a rat model of depression induced by chronic stress","volume":"41","author":"Yuedi","year":"2009","journal-title":"Acta Psychol Sin"},{"key":"10.1016\/j.regpep.2013.08.005_bb0160","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.1523\/JNEUROSCI.5320-05.2006","article-title":"Chronic valproic acid treatment triggers increased neuropeptide y expression and signaling in rat nucleus reticularis thalami","volume":"26","author":"Brill","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0165","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.peptides.2006.08.038","article-title":"Neuropeptide Y, (NPY) in neuroblastoma: effect on growth and vascularization","volume":"28","author":"Kitlinska","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2013.08.005_bb0170","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/0306-3623(94)00312-B","article-title":"The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release","volume":"26","author":"Vaughan","year":"1995","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0175","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0028-3908(99)00231-2","article-title":"Retinoic acid negatively regulates neuropeptide Y expression in human neuroblastoma cells","volume":"39","author":"Magni","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.regpep.2013.08.005_bb0180","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1006\/excr.2000.4843","article-title":"Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells","volume":"256","author":"Olsson","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.regpep.2013.08.005_bb0190","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1046\/j.1471-4159.1998.70051887.x","article-title":"Activated transcription of the human neuropeptide Y gene in differentiating SH-SY5Y neuroblastoma cells is dependent on transcription factors AP-1, AP-2alpha, and NGFI","volume":"70","author":"Wernersson","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.regpep.2013.08.005_bb0195","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.WNF.0000228209.69524.E8","article-title":"Therapeutic monitoring of valproate in psychiatry: how far have we progressed?","volume":"29","author":"Fleming","year":"2006","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0200","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0028-3908(02)00215-0","article-title":"Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium","volume":"43","author":"De Sarno","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.regpep.2013.08.005_bb0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02089958","article-title":"Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline","volume":"14","author":"Vandel","year":"1978","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0210","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1440-1819.2008.01838.x","article-title":"Plasma amitriptyline level after acute administration, and driving performance in healthy volunteers","volume":"62","author":"Iwamoto","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0215","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1523\/JNEUROSCI.1941-08.2008","article-title":"Nuclear factor kappa B signaling either stimulates or inhibits neurite growth depending on the phosphorylation status of p65\/RelA","volume":"28","author":"Gutierrez","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2199-10-57","article-title":"Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia","volume":"10","author":"Gubern","year":"2009","journal-title":"BMC Mol Biol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0225","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0230","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0028-3908(00)00009-5","article-title":"Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram","volume":"39","author":"Husum","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.regpep.2013.08.005_bb0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0014-2999(88)90182-3","article-title":"Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain","volume":"147","author":"Heilig","year":"1988","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0240","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0169-328X(98)00137-5","article-title":"Alterations in neuropeptide Y and Y1 receptor mRNA expression in brains from an animal model of depression: region specific adaptation after fluoxetine treatment","volume":"59","author":"Caberlotto","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0245","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2826.1996.04422.x","article-title":"Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats","volume":"8","author":"Baker","year":"1996","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0250","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.peptides.2006.07.025","article-title":"Gene therapy in epilepsy: the focus on NPY","volume":"28","author":"Noe","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.regpep.2013.08.005_bb0255","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2009.11.3\/jhunsberger","article-title":"The neurotrophic and neuroprotective effects of psychotropic agents","volume":"11","author":"Hunsberger","year":"2009","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0260","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12031-008-9122-2","article-title":"Evidence for involvement of ERK, PI3K, and RSK in induction of Bcl-2 by valproate","volume":"37","author":"Creson","year":"2009","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0265","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bjp.0700920","article-title":"Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells","volume":"120","author":"Connor","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0270","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/jcb.24422","article-title":"Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt\/survivin independently of HDAC inhibition","volume":"114","author":"Shah","year":"2013","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.regpep.2013.08.005_bb0275","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/sj.bjc.6602309","article-title":"Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells","volume":"92","author":"Stockhausen","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.regpep.2013.08.005_bb0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0006-8993(98)00471-5","article-title":"Cholinergic muscarinic mechanisms regulate neuropeptide Y gene expression via protein kinase C in human neuroblastoma cells","volume":"798","author":"Magni","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0285","first-page":"27","article-title":"Activation of the human NPY gene during neuroblastoma cell differentiation: induced transcriptional activities of AP-1 and AP-2","volume":"5","author":"Andersson","year":"1994","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.regpep.2013.08.005_bb0290","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0893-133X(96)00239-4","article-title":"Increase in AP-1 transcription factor DNA binding activity by valproic acid","volume":"16","author":"Chen","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.regpep.2013.08.005_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(99)00125-4","article-title":"Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos","volume":"70","author":"Chen","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0300","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1523\/JNEUROSCI.0514-08.2008","article-title":"Estrogen facilitates both phosphatidylinositol 3-kinase\/Akt and ERK1\/2 mitogen-activated protein kinase membrane signaling required for long-term neuropeptide Y transcriptional regulation in clonal, immortalized neurons","volume":"28","author":"Titolo","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0305","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00213-009-1551-2","article-title":"Early effects of mood stabilizers on the Akt\/GSK-3\u03b2 signaling pathway and on cell survival and proliferation","volume":"205","author":"Aubry","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.regpep.2013.08.005_bb0310","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1146\/annurev.biochem.68.1.965","article-title":"AKT\/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation","volume":"68","author":"Chan","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.regpep.2013.08.005_bb0315","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0301-0082(01)00011-9","article-title":"The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling","volume":"65","author":"Grimes","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0320","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuropharm.2009.01.008","article-title":"Valproic acid enhances protein l-isoaspartyl methyltransferase expression by stimulating extracellular signal-regulated kinase signaling pathway","volume":"56","author":"Cournoyer","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.regpep.2013.08.005_bb0325","doi-asserted-by":"crossref","first-page":"6590","DOI":"10.1523\/JNEUROSCI.5747-03.2004","article-title":"Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis","volume":"24","author":"Hao","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0330","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1399-5618.2004.00164.x","article-title":"Comparative analysis of the effects of four mood stabilizers in SH-SY5Y cells and in primary neurons","volume":"7","author":"Di Daniel","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.regpep.2013.08.005_bb0335","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/138945010790711923","article-title":"Valproic acid in the complex therapy of malignant tumors","volume":"11","author":"Hrebackova","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.regpep.2013.08.005_bb0340","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.neuropharm.2008.09.019","article-title":"Valproic acid promotes neuronal differentiation by induction of proneural factors in association with H4 acetylation","volume":"56","author":"Yu","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.regpep.2013.08.005_bb0345","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"S\u00e1nchez","year":"1999","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0350","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1213\/01.ane.0000260310.63117.a2","article-title":"Amitriptyline is a potent blocker of human Kv1.1 and Kv7.2\/7.3 channels","volume":"104","author":"Punke","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.regpep.2013.08.005_bb0355","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/npp.2009.75","article-title":"Antidepressants increase neural progenitor cells in the human hippocampus","volume":"34","author":"Boldrini","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.regpep.2013.08.005_bb0360","doi-asserted-by":"crossref","first-page":"e21660-e","DOI":"10.1371\/journal.pone.0021660","article-title":"Amitriptyline-mediated cognitive enhancement in aged 3\u00d7 Tg Alzheimer's disease mice is associated with neurogenesis and neurotrophic activity","volume":"6","author":"Chadwick","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.regpep.2013.08.005_bb0365","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.chembiol.2009.05.010","article-title":"Amitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA\/TrkB heterodimerization and has potent neurotrophic activity","volume":"16","author":"Jang","year":"2009","journal-title":"Chem Biol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0370","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1460-9568.2000.00941.x","article-title":"Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting","volume":"12","author":"Reibel","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.regpep.2013.08.005_bb0375","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0169-328X(95)00299-8","article-title":"BDNF increases the expression of neuropeptide Y mRNA and promotes differentiation\/maturation of neuropeptide Y-positive cultured cortical neurons from embryonic and postnatal rats","volume":"37","author":"Takei","year":"1996","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0380","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/cncr.25674","article-title":"The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan","volume":"117","author":"Zage","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.regpep.2013.08.005_bb0385","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1471-4159.2012.07766.x","article-title":"Type I interferons impair BDNF-induced cell signaling and neurotrophic activity in differentiated human SH-SY5Y neuroblastoma cells and mouse primary cortical neurons","volume":"122","author":"Dedoni","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.regpep.2013.08.005_bb0390","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.semcancer.2006.04.005","article-title":"Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation","volume":"17","author":"Edsj\u00f6","year":"2007","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0395","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2210-8-6","article-title":"Antidepressant drugs modulate growth factors in cultured cells","volume":"8","author":"Henkel","year":"2008","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0400","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.seizure.2012.05.001","article-title":"Valproate sodium enhances body weight gain in patients with childhood epilepsy: a pathogenic mechanisms and open-label clinical trial of behavior therapy","volume":"21","author":"Kanemura","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.regpep.2013.08.005_bb0405","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/0269881108091595","article-title":"Effect of valproic acid on body weight, food intake, physical activity and hormones: results of a randomized controlled trial","volume":"23","author":"Martin","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.regpep.2013.08.005_bb0410","first-page":"125","article-title":"Valproate-induced insulin resistance and obesity in children","volume":"71","author":"Verrotti","year":"2009","journal-title":"Horm Res"},{"key":"10.1016\/j.regpep.2013.08.005_bb0415","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1176\/ajp.155.1.12","article-title":"Mood stabilizer combinations: a review of safety and efficacy","volume":"155","author":"Freeman","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.regpep.2013.08.005_bb0420","doi-asserted-by":"crossref","first-page":"15043","DOI":"10.1073\/pnas.95.25.15043","article-title":"The neuropeptide Y\/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice","volume":"95","author":"Broberger","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2013.08.005_bb0425","first-page":"919","article-title":"The obesity pipeline: current strategies in the development of anti-obesity drugs","volume":"5","author":"Cooke","year":"2006","journal-title":"Nat Rev"},{"key":"10.1016\/j.regpep.2013.08.005_bb0430","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1210\/er.2007-0003","article-title":"Neuropeptide y receptor selective ligands in the treatment of obesity","volume":"28","author":"Kamiji","year":"2007","journal-title":"Endocr Rev"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011513001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011513001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:17:44Z","timestamp":1759072664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011513001250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":86,"alternative-id":["S0167011513001250"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2013.08.005","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line","name":"articletitle","label":"Article Title"},{"value":"Regulatory Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regpep.2013.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}